World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
76
Citations
16570
World Ranking
1939
National Ranking
134

Overview

Hinrich Abken is affiliated with the University of Regensburg in Germany. Their research focuses primarily on fields related to medicine, immunology and microbiology, and biochemistry, genetics, and molecular biology. The scientist has a significant publication record in oncology, immunology, molecular biology, genetics, and biomedical engineering as main subfields of study.

The core topics of Abken's research include:

  • CAR-T cell therapy research
  • Immune cell function and interaction
  • Viral infectious diseases and gene expression in insects
  • Virus-based gene therapy research
  • Immunotherapy and immune responses
  • Nanowire synthesis and applications
  • T-cell and B-cell immunology

Frequent co-authors collaborating with Hinrich Abken include:

  • Markus Barden
  • Astrid Holzinger
  • Axel Schambach
  • Claudia Rössig
  • Andreas Hombach

Abken has published multiple papers in journals and venues where they have contributed repeatedly, among them:

  • Frontiers in Immunology
  • Cells
  • Journal for ImmunoTherapy of Cancer
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Blood

Notable recent papers include:

  • "TRUCKS, the fourth-generation CAR T cells: Current developments and clinical translation" (2020), Advances in Cell and Gene Therapy
  • "Deregulation and epigenetic modification of BCL2-family genes cause resistance to venetoclax in hematologic malignancies" (2022), Blood
  • "Design and Characterization of an "All-in-One" Lentiviral Vector System Combining Constitutive Anti-GD2 CAR Expression and Inducible Cytokines" (2020), Cancers
  • "Trastuzumab derived HER2-specific CARs for the treatment of trastuzumab-resistant breast cancer: CAR T cells penetrate and eradicate tumors that are not accessible to antibodies" (2020), Cancer Letters
  • "IL7-IL12 Engineered Mesenchymal Stem Cells (MSCs) Improve A CAR T Cell Attack Against Colorectal Cancer Cells" (2020), Cells

Best Publications

  • TRUCKs: the fourth generation of CARs.

    Markus Chmielewski;Hinrich Abken

  • IL-12 release by engineered T cells expressing chimeric antigen receptors can effectively Muster an antigen-independent macrophage response on tumor cells that have shut down tumor antigen expression.

    Markus Chmielewski;Caroline Kopecky;Andreas A. Hombach;Hinrich Abken

  • CAR T Cells Releasing IL-18 Convert to T-Bethigh FoxO1low Effectors that Exhibit Augmented Activity against Advanced Solid Tumors

    Markus Chmielewski;Hinrich Abken

  • Of CARs and TRUCKs: chimeric antigen receptor (CAR) T cells engineered with an inducible cytokine to modulate the tumor stroma.

    Markus Chmielewski;Andreas A. Hombach;Hinrich Abken

  • Tumor-specific T cell activation by recombinant immunoreceptors: CD3 zeta signaling and CD28 costimulation are simultaneously required for efficient IL-2 secretion and can be integrated into one combined CD28/CD3 zeta signaling receptor molecule.

    Andreas Hombach;Anja Wieczarkowiecz;Thomas Marquardt;Claudia Heuser

  • T Cell Activation by Antibody-Like Immunoreceptors: Increase in Affinity of the Single-Chain Fragment Domain above Threshold Does Not Increase T Cell Activation against Antigen-Positive Target Cells but Decreases Selectivity

    Markus Chmielewski;Andreas Hombach;Claudia Heuser;Gregory P. Adams

  • Adoptive immunotherapy with genetically engineered T cells: modification of the IgG1 Fc 'spacer' domain in the extracellular moiety of chimeric antigen receptors avoids 'off-target' activation and unintended initiation of an innate immune response.

    A Hombach;A A Hombach;H Abken

  • OX40 costimulation by a chimeric antigen receptor abrogates CD28 and IL-2 induced IL-10 secretion by redirected CD4(+) T cells.

    Andreas A. Hombach;Johannes Heiders;Marcel Foppe;Markus Chmielewski

  • Epstein Barr virus–specific cytotoxic T lymphocytes expressing the anti-CD30ζ artificial chimeric T-cell receptor for immunotherapy of Hodgkin disease

    Barbara Savoldo;Cliona M. Rooney;Cliona M. Rooney;Antonio Di Stasi;Hinrich Abken

  • T Cells Expressing a Chimeric Antigen Receptor That Binds Hepatitis B Virus Envelope Proteins Control Virus Replication in Mice

    Karin Krebs;Nina Böttinger;Li–Rung Huang;Markus Chmielewski

  • Engineering antigen-specific primary human NK cells against HER-2 positive carcinomas

    Anna Kruschinski;Andreas Moosmann;Isabel Poschke;Håkan Norell

  • CAR-T cells and solid tumors: tuning T cells to challenge an inveterate foe.

    David E. Gilham;Reno Debets;Martin Pule;Robert E. Hawkins

  • Coexpressed Catalase Protects Chimeric Antigen Receptor–Redirected T Cells as well as Bystander Cells from Oxidative Stress–Induced Loss of Antitumor Activity

    Maarten A. Ligtenberg;Dimitrios Mougiakakos;Madhura Mukhopadhyay;Kristina Witt

  • The Analysis of Tyrosinase-Specific mRNA in Blood Samples of Melanoma Patients by RT-PCR Is Not a Useful Test for Metastic Tumor Progression

    Uwe Reinhold;Hans-Christian Lüdtke-Handjery;Hans-Christian Lüdtke-Handjery;Sylvia Schnautz;Hans-Wilhelm Kreysel

  • Antigen-Specific T-Cell Activation Independently of the MHC: Chimeric Antigen Receptor-Redirected T Cells.

    Markus Chmielewski;Andreas A. Hombach;Hinrich Abken

  • TRUCKS, the fourth‐generation CAR T cells: Current developments and clinical translation

    Unknown

  • Costimulation by chimeric antigen receptors revisited the T cell antitumor response benefits from combined CD28-OX40 signalling.

    Andreas A. Hombach;Hinrich Abken

  • T cells that target carcinoembryonic antigen eradicate orthotopic pancreatic carcinomas without inducing autoimmune colitis in mice.

    Markus Chmielewski;Olga Hahn;Gunter Rappl;Michael Nowak

  • T Cells Redirected Against Hepatitis B Virus Surface Proteins Eliminate Infected Hepatocytes

    Felix Bohne;Markus Chmielewski;Gregor Ebert;Katja Wiegmann

  • T-cell activation by recombinant receptors: CD28 costimulation is required for interleukin 2 secretion and receptor-mediated T-cell proliferation but does not affect receptor-mediated target cell lysis.

    Andreas Hombach;Dagmar Sent;Claudia Schneider;Claudia Heuser

  • Eradication of melanomas by targeted elimination of a minor subset of tumor cells

    Patrick Schmidt;Caroline Kopecky;Andreas Hombach;Paola Zigrino

Frequent Co-Authors

Andreas Hombach
Andreas Hombach University of Cologne
Volker Diehl
Volker Diehl University of Cologne
Michael Hallek
Michael Hallek University of Cologne
Ulrike Protzer
Ulrike Protzer Technical University of Munich
Barbara Seliger
Barbara Seliger Martin Luther University Halle-Wittenberg
Soldano Ferrone
Soldano Ferrone Harvard University
Wolfgang Uckert
Wolfgang Uckert Max Delbrück Center for Molecular Medicine
Robert E. Hawkins
Robert E. Hawkins University of Manchester
Gerold Schuler
Gerold Schuler University of Erlangen-Nuremberg
Martin Krönke
Martin Krönke University of Cologne

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in advancing their expertise alongside immunology, nursing-focused degrees offer valuable opportunities. Many professionals pursue a doctor of nursing practice salary that reflects advanced clinical and leadership roles across the USA. Understanding salary variations by state can help in making informed career decisions.

Transitioning within nursing specialties is also common. Programs like the fnp to acute care np bridge program allow family nurse practitioners (FNPs) to specialize further, expanding career options in acute care settings. This pathway is ideal for those seeking to enhance their clinical scope.

For faster completion, many students explore the accelerated fnp program, offering expedited routes to becoming a family nurse practitioner. These online programs are designed to balance rigorous training with flexibility.

Non-nurses eyeing entry into healthcare careers can benefit from 12-month accelerated nursing programs online for non nurses. These programs enable rapid entry into nursing through comprehensive, online curricula tailored for career changers.

Best Scientists Citing Hinrich Abken

Trending Scientists

Recently Published Articles